Getting to Approval Faster Through Technology Innovation
- Co-founder, Life Sciences Innovation
- Microsoft, United States
Paul Slater is the Worldwide Industry Strategist for Pharmaceuticals in the Microsoft Health Industry team. In this role, he is responsible for defining Microsoft’s life sciences strategy, developing strategic relationships and partnerships with key life sciences customers and partners, building industry-leading solutions that showcase Microsoft technologies, and educating the Microsoft internal community on the needs of the industry. Under Paul’s leadership, Microsoft is working with partners to develop innovative platforms and solutions that span the life sciences value chain from discovery and development, through manufacturing and distribution to commercialization.
Matt Neal, MA
- Senior Director, Product Management
- PAREXEL, United States
Matt Neal joined PAREXEL in 2016 as the Senior Director of Product Management for Regulatory Solutions. Before joining, Matt was a Director of Regulatory & Safety Operations at Amgen, Inc. and prior to that he was one of the pioneering members of the Regulatory Submissions Department for GlaxoSmithKline and has been publishing and submitting electronic dossiers to the FDA since 1996, and submitted the very first fully electronic NDA for GSK in 1999. Matt holds a Master’s Degree in Communication from Temple University.
Meredith K Sewell
- Executive Director, Global Regulatory Submissions
- Allergan, United States
Meredith Sewell is Allergan’s Director of Global Regulatory Affairs Operations and leads the Publishing, RIM and Archiving functions. Meredith joined the company in Irvine, CA in 2006 and in 2015, after Allergan merged with Actavis, Forest, Watson & Warner-Chilcott, she now leads a united team of 27 people in Allergan offices in the US, England, Australia, Brazil and Singapore.